RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MedCap AB (publ) Stock

MedCap AB (publ) Stocks 2024

MedCap AB (publ) Stocks

14.86 M

Ticker

MCAP.ST

ISIN

SE0009160872

WKN

A2ASQ7

In 2024, MedCap AB (publ) had 14.86 M outstanding stocks, a 0% change from the 14.86 M stocks in the previous year.

The MedCap AB (publ) Stocks history

YEARNUMBER OF STOCKS (undefined SEK)
2025e14.86
2024e14.86
202314.86
202214.81
202114.8
202014.35
201913.45
201813.43
201713.4
201613.4
201513.4
201413.46
201312.1
201212.1
201111.7
201011.7
200911.6
200811.6
200711.5
200610.5
20056.6
20046.6

MedCap AB (publ) shares outstanding

The number of shares was MedCap AB (publ) in 2023 — This indicates how many shares 14.857 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue MedCap AB (publ) earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates MedCap AB (publ)'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of MedCap AB (publ)’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating MedCap AB (publ)'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

MedCap AB (publ) Aktienanalyse

What does MedCap AB (publ) do?

MedCap AB (publ) is a Swedish company specializing in the development and marketing of medical products. The company was founded in 2006 by a group of experts in the medical industry. MedCap's business model is focused on developing and marketing innovative medical products. The company has two main business areas: Medical Devices and Diagnostics. In the Medical Devices area, MedCap develops products for various medical applications, including respiratory diseases, pain therapy, and wound care. In the Diagnostics area, the company offers diagnostic tests for various diseases, including infectious diseases and cancer. MedCap aims to improve medical care through innovative products. The company has introduced a range of groundbreaking products that offer higher effectiveness and more convenient use for patients. An example of a MedCap product is the Aeroneb® Pro. This is an advanced nebulizer device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. According to MedCap, the Aeroneb® Pro is the most effective nebulizer device of its kind, offering higher medication absorption through the lungs than other nebulizer devices. Another MedCap product is the ClipOn® Pain Relief. This is a portable pain reliever used to alleviate pain from various diseases such as arthritis and back pain. According to MedCap, the ClipOn® Pain Relief is a fast and safe way to relieve pain and improve patients' quality of life. In the Diagnostics area, MedCap offers a range of diagnostic tests for infectious diseases, including HIV, hepatitis, and tuberculosis. An example of a MedCap diagnostic test is the Diagnostics Quick Test (DQT), a rapid test for HIV detection. According to MedCap, the DQT is the fastest HIV test on the market, providing results in just 15 minutes. MedCap has also focused on the field of personalized medicine. The company has developed a platform called Confero that enables doctors to offer personalized medicine to their patients. Confero utilizes artificial intelligence and machine learning to provide accurate diagnosis and treatment for each patient. Overall, MedCap has established itself as a leading company in the medical industry, offering innovative products and services for medical care. The company has a strong presence in Europe and is also expanding into other parts of the world. MedCap aims to improve medical care through its products and services, making a positive impact on the lives of patients. MedCap AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating MedCap AB (publ)'s Shares Outstanding

MedCap AB (publ)'s shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in MedCap AB (publ)’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding MedCap AB (publ)’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in MedCap AB (publ)’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about MedCap AB (publ) stock

How many stocks are there of MedCap AB (publ)?

The current number of stocks of MedCap AB (publ) is 14.86 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of MedCap AB (publ) are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of MedCap AB (publ) evolved in recent years?

The number of shares of MedCap AB (publ) has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. MedCap AB (publ) as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of MedCap AB (publ)?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does MedCap AB (publ) pay?

Over the past 12 months, MedCap AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MedCap AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of MedCap AB (publ)?

The current dividend yield of MedCap AB (publ) is .

When does MedCap AB (publ) pay dividends?

MedCap AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MedCap AB (publ)?

MedCap AB (publ) paid dividends every year for the past 0 years.

What is the dividend of MedCap AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is MedCap AB (publ) located?

MedCap AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von MedCap AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MedCap AB (publ) from 11/5/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did MedCap AB (publ) pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of MedCap AB (publ) in the year 2023?

In the year 2023, MedCap AB (publ) distributed 0 SEK as dividends.

In which currency does MedCap AB (publ) pay out the dividend?

The dividends of MedCap AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MedCap AB (publ)

Our stock analysis for MedCap AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedCap AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.